The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration. [PDF]
Zhang J +6 more
europepmc +1 more source
Real-world lesion-level outcomes and toxicity after external beam radiation therapy for oligometastatic prostate cancer among patients receiving Lu-PSMA-617. [PDF]
Lee E +8 more
europepmc +1 more source
Metastasis-directed therapy in addition to definitive locoregional radiotherapy for De novo metastatic nasopharyngeal carcinoma: a retrospective cohort study. [PDF]
Laskar SG +28 more
europepmc +1 more source
Novel strategies in radiation therapy: high-dose radiotherapy for oligometastatic/oligo-progressive thymic tumors. [PDF]
Alaverdashvili T, Rimner A.
europepmc +1 more source
Oligometastatic GIST: Impact of Treatment Modalities and Metastatic Distribution on Overall Survival. [PDF]
Pearce WH +15 more
europepmc +1 more source
External validation of a genomic signature for oligometastatic non-small cell lung cancer
Objective: We previously presented a genomic signature predictive of both oligometastatic disease state and oligoprogression in patients with brain metastases.
Xing, Fei +17 more
core
Surviving Cancer, Lacking Support: The Hidden Burden of Modern Radiation Oncology in the Treatment of Oligometastatic Disease. [PDF]
Chasty B +3 more
europepmc +1 more source
Efficacy and Safety of Moderate-Dose Stereotactic Body Radiation Therapy (SBRT) for Patients with Oligometastatic Lung Cancer Unfit for Standard SBRT: A Preliminary Single-Center Study. [PDF]
Park J, Bae BK, Kang MK, Park J.
europepmc +1 more source
Hormone receptor-positive HER2-negative oligometastatic breast cancer: prognostic stratification and pattern of progression. [PDF]
Lacaze JL +12 more
europepmc +1 more source

